What does Kailera Therapeutics, Inc. do?
Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs…
What is Kailera Therapeutics, Inc.'s P/E and P/B ratio?
Kailera Therapeutics, Inc. has a P/E ratio of -2.9 and a P/B ratio of 1.54.
What is Kailera Therapeutics, Inc.'s debt-to-equity ratio?
Kailera Therapeutics, Inc. has a debt-to-equity ratio of 0.01.
How much does Kailera Therapeutics, Inc. owe compared with what it owns?
Kailera Therapeutics, Inc. owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Kailera Therapeutics, Inc.'s Positivity rank?
Kailera Therapeutics, Inc. is ranked #2,696 of 6,774 companies globally and #936 of 4,000 in United States on PositoAI, with a Positivity Score of 21,225.
Does Kailera Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Kailera Therapeutics, Inc..
Where can I read the latest news about Kailera Therapeutics, Inc.?
Recent headlines about Kailera Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Kailera Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Kailera Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.